Chantix
Chantix: The Stop Smoking Drug
By Brian Welsch
Chantix, a patently new stop smoking medication, was approved by Food and Drug Administration (FDA) in the year 2006 and is obtainable in the pill form. The usage of this drug is not recommended during pregnancy or for people under 18 years old. In addition, researchers strongly discourage the use of this stop smoking drug with additional smoking-cessation products.
In the review by the Food and Drug Administration, the emphasis was given to a new medication, called Varenicline tartrate, which is an active agent in Chantix. The presence of this chemical is so crucial that it took only 6 months for the consent as opposed to the regular 10 months of regular evaluations. It is primarily because of the fact that the results showed a higher rate of smoking cessation than Zyban, a different stop smoking drug approved by FDA.
12 Weeks of Treatment
The suggested line of intervention with Chantix is decided as 12 weeks. However, longer treatment may become sometimes required for some persons. This stop smoking medication should not be used on its own; counseling and behavior therapy are also used as an integral part of the treatment process. An extra 12 weeks of treatment intervention may enhance the chance of smoking cessation for prolonged time period.
The chemical reaction of Chantix is the same as nicotine as it virtually affects the identical places. Essentially the function of Chantix can be categorized under two heads:
(1) providing effects resembling the nicotine action for easing withdrawal symptoms and(2) blocking the effect of nicotine since it holds the same synaptic sites, if the persons resume their smoking habit once again.
Cigarette smoking is a actually complex habit to break since nicotine addiction plays the leading role here. The therapy based on the Chantix stop smoking medication, is found to be effective for many smokers since it assists in motivating them to stop. Numerous healthcare professionals successfully use this stop smoking medication therapy in order to offer aid to the hundreds of millions of smokers who are really willing to quit their smoking habit.
Possible Outcomes
The efficiency of this stop smoking drug in smoking cessation was revealed with the help of six clinical tests. As discovered in the study, the effect of 12 weeks of treatment for Chantix was far superior to another smoking cessation products like Zyban. Although there is a great number of benefits associated with Chantix, the usage of this stop smoking drug may offer few unavoidable side effects such as nausea, altered taste perception, insomnia, vomiting, insomnia, headache and unusual dreams.
Find more related articles in our Stop Smoking Guide
